Coordinated Action on Respiratory Viruses (CA52)
The Respiratory Viruses Coordinated action was created following the REACTing and ANRS MIE workgroups on COVID-19.
Last updated on 12 November 2024
In brief
The objective of the Coordinated Action is to lead the scientific community and support innovative research projects in the field of respiratory viruses, with the aim to submit them to the various Calls for Proposals.
Activities
- Scientific leadership on respiratory viruses: identification of research priorities and support for research projects covering the scope of clinical research on viruses linked to various respiratory viruses (including SARS-CoV-2, Influenza, RSV, Metapneumovirus, PIV), from pathophysiology to therapeutic and public health studies.
- Project support
Chair and Co-Chair
Karine Lacombe
Sorbonne University, Inserm UMR-S1136, IPLESP Head of the Department of Infectious and Tropical Diseases, Hôpital St Antoine, Paris
Edouard Lhomme
MCU-PH Public Health, ISPED, Bordeaux Population Health (Inserm U1219), Bordeaux University Hospital
ANRS MIE coordination
Chloé Duquesnay
(Administrative Coordinator for Scientific Bodies)
Manon Ollivier
(Project Manager)
Eric Rosenthal (Scientific Advisor)
Members
Notre sélection
2nd Workshop of the coordinated action on respiratory viruses
The 2nd Workshop of the ANRS MIE coordinated action (CA) on respiratory viruses will be held in Paris on 2 and 3 December 2024.
12 November 2024